Drugs / Salmeterol/fluticasone propionate
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00169546 | Jan 2003 → Dec 2005 | asthma | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Salmeterol/fluticasone propionate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00169546 ↗ |
| Route | Inhaled | “SERETIDE DISKUS ® Inhlaer 50/100mcg Twice Daily” NCT00169546 ↗ |